Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

Abstract
PURPOSEThe population pharmacokinetic/pharmacodynamic (PK/PD) approach was prospectively integrated in the clinical development of docetaxel to assess the PK profile in a large population of patien...